Aima Diagnostics

by Aima Diagnostics  · Based in France → — Advanced Liquid Biopsy Technology
Cardiology Endocrinology Family Medicine
Website Contact
Claim this tool
Is this the maker? Claim the company →

Overview

Aima Diagnostics leverages advanced artificial intelligence to provide personalized interpretations of blood test results. The platform is designed to assist individuals, physicians, and clinics in understanding complex biomarker data within the context of an individual’s unique health profile. By moving beyond standard reference ranges, Aima Diagnostics aims to identify subtle patterns and potential health risks earlier than traditional methods.

For physicians, Aima Diagnostics offers a sophisticated tool to enhance diagnostic capabilities and inform treatment decisions. The AI analyzes a broad spectrum of biomarkers, considering individual factors such as age, gender, lifestyle, and medical history. This comprehensive approach helps clinicians gain deeper insights into a patient’s health status, facilitating proactive interventions and personalized care plans.

The technology focuses on early disease detection, allowing for timely interventions that can significantly improve patient outcomes. By providing a more nuanced understanding of blood test results, Aima Diagnostics empowers healthcare providers to make more informed decisions, optimize patient management, and potentially reduce the burden of advanced disease.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered biomarker analysis
  • Personalized health insights
  • Early disease detection
  • Contextual interpretation of blood tests
  • Support for physicians and clinics
  • Advanced liquid biopsy technology

Use Cases

  • Early detection of chronic diseases
  • Personalized risk assessment
  • Informing treatment strategies
  • Monitoring patient health trends
  • Enhancing diagnostic accuracy

What Physicians Need to Know

Evidence Base (guidelines, literature scope)
Aima Diagnostics' AI algorithms are trained on millions of anonymized laboratory records and clinical cases. The platform's interpretations are based on research from Harvard Medical School, Mayo Clinic, and WHO guidelines. They also adhere to CLSI EP28-A3c standards for reference intervals and incorporate data from the EFLM Biological Variation Database. Aima Diagnostics publishes white papers and technical reports, and contributes to peer-reviewed scientific publications and conference presentations. They have also developed 'Standards for AI-Based Blood Data Processing'.
Clinical Validation Studies
Aima Diagnostics follows a research-driven methodology for AI model development and validation, combining retrospective and prospective clinical data analysis, longitudinal biomarker tracking, and statistically validated pattern discovery. All AI models are evaluated against clinically relevant endpoints, including sensitivity, specificity, and real-world diagnostic utility. The platform is continuously refined through collaboration with physicians, clinics, and laboratories. One example of a clinical validation study for an AI-based blood testing device (TriVerity, which uses machine learning on blood mRNAs) showed clinically acceptable performance in diagnosing bacterial and viral infections and predicting the need for critical care interventions. This study reported an AUROC of 0.83 for bacterial infection diagnosis and 0.91 for viral infection.
Alert Fatigue Management
While Aima Diagnostics doesn't explicitly detail its alert fatigue management strategies, its approach to providing comprehensive, personalized, and data-driven reports aims to offer actionable insights rather than just flagging abnormal results. The system analyzes interconnections between indicators and considers individual factors, which could inherently reduce irrelevant alerts by providing more contextually relevant information. The platform's goal is to provide reliable decision support that saves time and reduces errors, which indirectly addresses the burden that can lead to alert fatigue.
Differential Diagnosis Support
Aima Diagnostics provides comprehensive medical analysis by evaluating each biomarker in the context of the overall physiological picture, including hormones, vitamins, enzymes, lipid profiles, and metabolic balance. The algorithms analyze relationships between physiological systems to detect functions under strain, even when individual values appear normal. This personalized approach, which incorporates age, sex, lifestyle, and geographic region, helps reveal subtle irregularities that standard methods often overlook. The reports include explanations for each biomarker, possible causes of deviations, and personalized health and lifestyle recommendations.
Guideline Update Frequency
Aima Diagnostics' 'Standards for AI-Based Blood Data Processing' was updated to Version 1.2 in July 2025. The platform is continuously refined through collaboration with physicians, clinics, and laboratories, enabling the incorporation of real-world use cases and challenges. Their analytical model is designed for continuous improvement. All data is verified as of September 2025 based on current publications and official medical guidelines.
Clinical Workflow Integration
Integrating Aima AI Diagnostics into a clinic's workflow is designed to be seamless and enhance efficiency without requiring major changes. Clinics can implement AI-powered blood diagnostics through API integration or selective AI testing. The Aima system can be seamlessly connected to existing Electronic Health Records (EHR) and Laboratory Information Management Systems (LIMS) via API. This integration aims to automate routine tasks, improve workflow efficiency, and reduce data processing time.
Decision Audit Trail
Aima Diagnostics emphasizes data security and regulatory compliance, stating that all systems must comply with GDPR, HIPAA, or applicable national data protection regulations. All access and changes must be logged with immutable audit trails, retained for a minimum of 10 years. For clinical decision support, audit trails should include source data, processing steps, and confidence scores for each automated decision. If a clinician overrides an AI recommendation, the system must log both the original AI suggestion and the human decision, along with the rationale for the override.
Physician Tip

Aima Diagnostics serves as a powerful decision-support tool, augmenting clinical expertise by providing fast, accurate, and personalized interpretations of blood test results. Leverage its ability to analyze trends over time and interconnections between biomarkers to detect early signs of dysfunction that might be missed by traditional methods. The comprehensive reports, including possible causes of deviations and personalized recommendations, can be valuable for patient education and shared decision-making. Remember that Aima Diagnostics provides analytical support and does not replace professional medical judgment, diagnosis, or treatment decisions.

Aima Diagnostics offers seamless integration with existing Electronic Health Records (EHR) and Laboratory Information Management Systems (LIMS) via API, allowing for streamlined workflows and efficient data exchange. This enables clinics and laboratories to incorporate AI-powered blood diagnostics without major changes to their current infrastructure.

Details

Category Clinical Decision Support & Reference, Lab & Diagnostics, Oncology AI
Pricing Unknown
  • Aima Diagnostics offers different plans for clinics and laboratories, including API integration or selective AI testing
  • Pricing for these services is not publicly available
DeploymentCloud-based, API integration, or selective AI testing.
Mobile AppNone
API AvailableUnknown
LanguagesEnglish
TrainingUnknown
Target SizeLaboratories and clinics aiming for maximum accuracy and compliance with quality standards, private clinics, telemedicine services, and mobile diagnostic centers.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Unknown AI-estimated

Aima Diagnostics' AI diagnostic suggestions are presented as clinical decision support, not final diagnoses, unless the AI system is certified as a medical device.
GDPRUnknown AI-estimated
Integrations
EHR Not specified
Specialties Cardiology, Endocrinology, Family Medicine, Gastroenterology, Internal Medicine, Oncology

Social Proof

Customersunknown

Support & Reliability

Training ProvidedUnknown

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Aima Diagnostics

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Aima Diagnostics
Aima Diagnostics Introduces Optional Blockchain Recording for Blood Test Interpretations
Aima Diagnostics is developing a mechanism for recording interpretations of laboratory blood test results on the blockchain, ensuring immutability and transparency for verification by third parties. This optional feature, planned for patients in the UK and US, allows users to retain full control over their data.
2026-03
Aima Diagnostics
Partnership with One of Eastern Europe's Largest and Most Respected Laboratory Networks
Aima Diagnostics announced a partnership with ArtMediuz, a large laboratory network in Eastern Europe, to advance AI-powered laboratory test interpretation. This collaboration aims to enhance diagnostic precision and refine Aima Diagnostics' algorithms with real-world data and clinical expertise.
2025-10
Aima Diagnostics
The Augmentation of Clinical Practice: How Aima Diagnostics is Redefining Blood Test Interpretations
This article discusses how AI platforms like Aima Diagnostics are transforming blood test interpretation by providing instantaneous, structured analysis, allowing physicians to focus on clinical reasoning. It emphasizes the distinction between specialized medical AI and general-purpose models for diagnostic accuracy and patient safety.
unknown
Aima Diagnostics
What Your Blood Test Reveals: AI Case Study on Preventing Late Anemia Diagnosis
Aima Diagnostics presents a case study demonstrating how its AI detected hidden anemia in a 40-year-old man, preventing a late diagnosis through personalized interpretation. The article highlights the importance of considering individual factors like gender, age, and lifestyle for accurate lab result analysis.
2025-09
Aima Diagnostics
From Reaction to Foresight: How AI-Powered Blood Test Interpretation Is Reshaping the Paradigm of Clinical Diagnosis
This article explores how AI-powered blood test interpretation, like that offered by Aima Diagnostics, is moving medicine from reactive to proactive by detecting hidden correlations and temporal patterns in lab data. It emphasizes the need for independent clinical validation, peer-reviewed publications, and regulatory compliance for AI in healthcare.
unknown
Aima Diagnostics
Medical Laboratory Analyses and Health Issues of Jeffrey Epstein: Analysis of the Declassified Documents
Aima Diagnostics published an analysis of declassified documents related to Jeffrey Epstein's health, demonstrating the potential of AI tools for interpreting complex laboratory profiles. The article suggests that AI-based methodologies can enhance early detection and risk stratification by accounting for demographic, behavioral, and clinical contexts.
2026-03
Aima Diagnostics
Standards for AI-Based Blood Data Processing
Aima Diagnostics proposes standards for AI-based blood data processing, focusing on open collaboration, peer review, and harmonization with international regulatory bodies. These standards cover data revalidation, dual-AI architecture, regulatory compliance, and interoperability to ensure accuracy and patient safety.
unknown
clawRxiv
Agentic AI in an A&E Setting
This paper examines the integration of agentic artificial intelligence into Accident & Emergency settings to improve patient outcomes through enhanced diagnosis, coordination, and resource allocation. It references Aima Diagnostics in the context of 'Blood Diagnostics Trends 2025: AI, Genomics, and More.'
2026-03

Videos

Product demos, reviews, and walkthroughs for Aima Diagnostics.

View all on YouTube

Frequently Asked Questions

Aima Diagnostics utilizes AI to analyze various patient data points, offering predictive insights into disease progression and treatment response. This can help physicians in identifying at-risk patients earlier and tailoring treatment plans more effectively, potentially reducing diagnostic ambiguity.
Aima Diagnostics implements robust data encryption and anonymization protocols to protect patient information, ensuring full compliance with HIPAA, GDPR, and other relevant data privacy regulations. Data access is strictly controlled and audited, with all processing occurring on secure, compliant servers.
Aima Diagnostics offers flexible integration options, including APIs for seamless connection with most EMR systems. The integration process is typically guided by our technical support team, and we provide comprehensive training modules for physicians and their staff to ensure smooth adoption and effective usage.
Aima Diagnostics has demonstrated superior accuracy in several clinical studies compared to traditional diagnostic methods, often identifying subtle patterns missed by conventional approaches. Its AI-driven analysis significantly reduces the time to diagnosis, leading to more efficient patient management.
While Aima Diagnostics strives for unbiased algorithms, potential limitations related to data input or specific patient populations are continuously monitored. Our development team employs diverse datasets for training and regularly audits the AI for biases, implementing refinements to ensure equitable and accurate insights across all patient demographics.
Aima Diagnostics offers a tiered pricing model designed to accommodate practices of all sizes, from individual practitioners to large hospital systems. Options include per-use fees, monthly subscriptions, and enterprise-level agreements, with detailed quotes provided after an initial consultation to assess specific needs.
Aima Diagnostics provides continuous support, including a dedicated helpdesk, regular software updates with new features and algorithm enhancements, and access to a knowledge base. We are committed to ensuring our platform evolves with the latest medical research and technological advancements.

Compare Aima Diagnostics

VS
Avenda Health AI Prostate Cancer Planning Software vs Aima Diagnostics
Clinical Decision Support & Reference Adjacent · 60/100
Avenda Health's Unfold AI is specifically designed for prostate cancer treatment planning, generating 3D maps from various patient data to aid in surgical and treatment decisions. Aima Diagnostics,…
VS
ChatGPT vs Aima Diagnostics
Clinical Decision Support & Reference Adjacent · 65/100
ChatGPT for Healthcare is a broad generative AI platform designed to support various clinical and administrative workflows, offering features like summarization, drafting, and clinical search with citations. Aima…
VS
OpenEvidence vs Aima Diagnostics
Clinical Decision Support & Reference Adjacent · 65/100
OpenEvidence is an AI-powered clinical decision support platform that provides physicians with immediate, referenced answers from peer-reviewed medical literature and offers tools for clinical documentation, including transcribing patient…
VS
23andMe Personal Genome Service (PGS) Genetic Health Risk Test for Hereditary Thrombophilia vs Aima Diagnostics
Clinical Decision Support & Reference Adjacent · 65/100
23andMe's tool focuses on providing direct-to-consumer genetic risk information for hereditary thrombophilia through saliva-based DNA testing. Aima Diagnostics, conversely, offers AI-powered interpretation of a broader range of blood…

Related Tools

DeepMind (Google)
Google DeepMind
Clinical Decision Support & Reference
AlphaFold is an AI system developed by DeepMind (Google) that accurately predicts protein structures and their interactions, significantly accelerating biological and medical research.
Free for non-commercial use
Tempus AI
Tempus AI
Clinical Decision Support & Reference
Tempus ECG-AI Platform uses artificial intelligence to analyze electrocardiogram data, offering advanced insights for cardiovascular diagnosis and management.
Cortex
Cortex
Clinical Decision Support & Reference
Cortex Workspace is a secure, HIPAA-compliant AI platform designed to streamline healthcare workflows and enhance decision-making for physicians.
Starts free, then $29/month for individual plan (save 10% annually). other plans: enthusiast ($99/month), business ($349/month), enterprise (contact sales).
SureMediks ProView
SureMediks (Rasimo Systems, LLC)
Clinical Decision Support & Reference
SureMediks is an AI-powered clinical decision support and metabolic health platform that automates care workflows for specialists, providing AI-generated patient summaries, automated chart review, and real-time biometric alerts.
SOAP Health
SOAP Health
Clinical Decision Support & Reference
SOAP Health is a Florida-based startup transforming patient intake with AI-powered diagnosis, offering a comprehensive solution that improves diagnosis accuracy and empowers patients and physicians.
Oxipit ChestLink
Oxipit (part of Sectra group)
Clinical Decision Support & Reference
Oxipit ChestLink is the world's first CE Class IIb-certified autonomous AI application for healthy chest X-ray reporting, capable of identifying normal studies with 99.9% sensitivity. It automates the reporting of normal chest X-rays, reducing radiologist workload and improving efficiency.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Last Verified: 2026-06-12 | First Added: 2026-06-12
AI Tool Finder
AI-powered search. Results may not be comprehensive.